Results 161 to 170 of about 10,514 (181)

Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant <i>Enterobacterales</i>. [PDF]

Microbiol Spectr
Meng Q, Xu C, Li W, Shen K, Huang X, Fu X, Zhou L, Chen Y, Hu F, Wang H.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production

FEMS Microbiology Letters, 1999
openaire   +1 more source

Characterisation of CMY-4, an AmpC-type plasmid-mediated β-lactamase in a Tunisian clinical isolate of Proteus mirabilis

FEMS Microbiology Letters, 1998
openaire   +1 more source

Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae

Clinical Microbiology Reviews, 2018
Jesús Rodríguez-Baño, Belén Gutiérrez-Gutiérrez, Alvaro Pascual   +2 more
exaly  

Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective

Clinical Microbiology and Infection, 2012
Torsten Semmler, Sebastian Guenther
exaly  

Detection of Plasmid-Mediated AmpC  -Lactamase Genes in Clinical Isolates by Using Multiplex PCR

Journal of Clinical Microbiology, 2002
Nancy D Hanson
exaly  

Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins

Antimicrobial Agents and Chemotherapy, 2015
katy Jeannot, isabelle Broutin, Patrick Plesiat   +2 more
exaly  

AmpC β-lactamase-producing Enterobacterales: what a clinician should know

Infection, 2019
Simone Meini, Carlo Tascini, Emanuela Sozio   +2 more
exaly  

Molecular relatedness of ESBL/AmpC-producing Escherichia coli from humans, animals, food and the environment: a pooled analysis

Journal of Antimicrobial Chemotherapy, 2018
Ad C Fluit, , Joost Hordijk
exaly